search
for
 About Bioline  All Journals  Testimonials  Membership  News


European Journal of General Medicine
Medical Investigations Society
ISSN: 1304-3897
Vol. 7, No. 4, 2010, pp. 433-435
Bioline Code: gm10083
Full paper language: English
Document type: Case Report
Document available free of charge

European Journal of General Medicine, Vol. 7, No. 4, 2010, pp. 433-435

 en Aripiprazole in Delusional Disorder
Duvar, Halide; Şengül, Cem & Herken, hasan

Abstract

Though it has been known for a long time, due to the fact that the controlled studies are limited and the disorder is uncommon, case reports have been important supporting the data of the treatments. In general, depending on whether the patient used drug before and considering the effects and side effects of the drugs the first choice in the treatment is antipsychotic drugs. New atypical antipsychotic agents are preferred for their relatively less side effects and higher drug adaptation. We aimed to report a case of delusional disorder (jealous type) which did not respond to different atypical antipsychotic agents previously but shows a prognostic improvement by aripiprazole of 30mg/day. Aripiprazole may be an effective option for the treatment of delusional disorder, with few side effects, high drug compliance and efficacy.

Keywords
Delusional disorder, aripiprazole, treatment

 
© Copyright 2010 - European Journal of General Medicine
Alternative site location: http://www.ejgm.org

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil